Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00901225 · OUTCOME

Number of Participants Experiencing a Grade III/IV Toxicity

Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant · Source last updated 2014-05-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
6 months post transplant or until relapse

What was measured

Safety of plerixafor as measured by Grade III/IV Toxicity

Groups in this outcome

G-CSF Plus Plerixafor

Patients who were unable to mobilize a minimum number of cells (CD34+ cell count \<20 cells/ul)following 5 days of G-CSF mobilization.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
G-CSF Plus Plerixafor20

Reported measurements

Source class 1
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
G-CSF Plus Plerixafor0Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        0
denoms
  1. counts
    1. group Id
      OG000
      value
      20
    units
    Participants
description
Safety of plerixafor as measured by Grade III/IV Toxicity
groups
  1. description
    Patients who were unable to mobilize a minimum number of cells (CD34+ cell count \<20 cells/ul)following 5 days of G-CSF mobilization.
    id
    OG000
    title
    G-CSF Plus Plerixafor
param Type
NUMBER
reporting Status
POSTED
time Frame
6 months post transplant or until relapse
title
Number of Participants Experiencing a Grade III/IV Toxicity
type
SECONDARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice